EODData

MEMBERSHIP REGISTER LOG IN

FRA, GBY: Sangamo Therapeutics Inc

04 Nov 2025
LAST:

0.4766

CHANGE:
 0.03		OPEN:
0.4766		HIGH:
0.4766		ASK:
0.0000		VOLUME:
7.5K
CHG(%):
6.65		PREV:
0.4469		LOW:
0.4766		BID:
0.0000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
04 Nov 250.47660.47660.47660.47667.5K
03 Nov 250.48780.48780.44690.44697.5K
31 Oct 250.48060.48060.45810.45817.5K
30 Oct 250.48190.52360.44070.44077.5K
29 Oct 250.47740.47740.45000.45001.5K
28 Oct 250.51410.51410.45420.45421.5K
27 Oct 250.53150.53150.48590.48591.5K
24 Oct 250.53660.53660.49870.49871.5K
23 Oct 250.53210.59460.51040.51041.5K
22 Oct 250.53510.53510.53510.5351300

COMPANY PROFILE

Name:Sangamo Therapeutics Inc
About:Sangamo Therapeutics, Inc., a clinical-stage genomic medicine company, focuses on translating science into medicines that transform the lives of patients and families afflicted with serious diseases in the United States. The company's clinical-stage product candidates are ST-920, a gene therapy product candidate, which is in Phase 1/2 clinical study for the treatment of Fabry disease; TX200, a chimeric antigen receptor engineered regulatory T cell (CAR-Treg) therapy product candidate that is in Phase 1/2 clinical study for the prevention of immune-mediated rejection in HLA-A2 mismatched kidney transplantation; and SB-525, a gene therapy product candidate, which is in Phase 3 clinical trial for the treatment of moderately severe to severe hemophilia A. Its preclinical development products focus on tauopathies, ALS/FTD, and huntington's diseases Sangamo Therapeutics, Inc. has collaborative and strategic partnerships with Biogen MA, Inc.; Kite Pharma, Inc.; Pfizer Inc.; Sanofi S.A.; Novartis Institutes for BioMedical Research, Inc.; Shire International GmbH; Dow AgroSciences LLC; Sigma-Aldrich Corporation; Genentech, Inc.; and Open Monoclonal Technology, Inc. The company was formerly known as Sangamo BioSciences, Inc. and changed its name to Sangamo Therapeutics, Inc. in January 2017. The company was incorporated in 1995 and is headquartered in Richmond, California.
Sector:Healthcare
Industry:Biotechnology
Address:501 Canal Blvd, Richmond, CA, United States, 94804
Website:https://www.sangamo.com
ISIN:US8006771062
LEI:2549006WMRKRC4G32Z67

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-0.97 
Forward P/E:-0.36 
PEG Ratio:0.02 
Price to Sales:2.01 
Price to Book:6.78 
Profit Margin:-0.77 
Operating Margin:-0.98 
Return on Assets:-0.41 
Return on Equity:-2.92 
Revenue:70.78M 
Shares:301.71M 
Market Cap:143.79M 

TECHNICAL INDICATORS

MA5:0.454.9%
MA10:0.480.2%
MA20:0.516.8%
MA50:0.480.2%
MA100:0.447.8%
MA200:0.5718.8%
STO9:23.33
STO14:23.33
RSI14:36.80 
WPR14:-66.67
MTM14:-0.02
ROC14:-0.05 
ATR:0.04 
Week High:0.529.9%
Week Low:0.448.1%
Month High:0.6231.1%
Month Low:0.4418.8%
Year High:2.93515.4%
Year Low:0.3346.6%
Volatility:22.37